Posts by Nneka N. Ufere, MD, MSCE
-
Healthcare–related Transportation Insecurity Is a Critical Social Risk Factor in Chronic Liver Disease
Nneka N. Ufere, MD, MSCE, Marina Serper, MD, MS, and colleagues found using nationwide U.S. data that 6% of patients with chronic liver disease report healthcare–related transportation insecurity, which about doubled the risk of mortality even after adjustment for income and other social risk factors.
-
Very Few Older Adults Are Included in Trials of IBD Medications
Only 0.9% of patients in recent randomized, controlled trials of medications for inflammatory bowel disease were ≥65 years old, and for trials of biologic agents, the figure was 0.5%, Massachusetts General Hospital researchers determined based on the first systematic review of this issue.
-
Care Coordination Needed to Reduce Readmission of End-stage Liver Disease Patients
To reduce hospital readmission of patients with newly diagnosed end-stage liver disease, transitional care is needed that attends to the informational, psychosocial and practical needs of these patients and their caregivers.
-
Patients with Decompensated Cirrhosis Need Earlier End-of-Life Planning
Regardless of transplant candidacy, patients with decompensated cirrhosis spend a substantial portion of their last 90 days of life in the hospital, are likely to receive intensive interventions at the end of life and tend to be referred late, if at all, to palliative or hospice care.
-
Advance Care Planning Needed Earlier for Patients with End-stage Liver Disease
Using a web-based survey of hepatologists and gastroenterologists, Massachusetts General Hospital researchers have identified substantial barriers to palliative and end-of-life care for patients with end-stage liver disease—and they say advance care planning needs to start earlier.
Biography
Nneka N. Ufere, MD, MSCE, is a Transplant Hepatologist in the Division of Gastroenterology within the Department of Medicine at Massachusetts General Hospital and Harvard Medical School in Boston, MA.
She completed an A.B. in Molecular and Cellular Biology with a minor in Psychology at Harvard College in 2008. She completed her medical degree at Washington University in St. Louis School of Medicine in 2012 where she was a recipient of the Glasgow-Rubin Citation for Academic Achievement and was inducted into the Alpha Omega Alpha Honor Medical Society. She completed her residency training in internal medicine at Massachusetts General Hospital, where she also served as a Chief Medical Resident during the 2016-2017 academic year. She completed her Gastroenterology fellowship in 2020 and Transplant Hepatology fellowship in 2021 at Massachusetts General Hospital. She is currently pursuing a Master of Science in Clinical Epidemiology degree at the at the Harvard T. H. Chan School of Public Health.
She is a member of the Massachusetts General Hospital Cancer Outcomes Research and Education Program, and her research interests center around palliative and supportive care and informed decision-making with the goal of developing interventions aimed at improving the quality of life and care for patients with advanced liver disease and their caregivers. Her work is currently supported by the American Association for the Study of Liver Diseases Clinical, Translational and Outcomes Research Award, the Massachusetts General Hospital Physician Scientist Development Award, an NIH Loan Repayment Award and a GI Innovation and Collaboration Award from the Mass General GI Division. She is a past recipient of the American College of Gastroenterology Clinical Research Pilot Award and the American Association for the Study of Liver Diseases Advanced/Transplant Hepatology Award.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.